HRA Pharma
Kelly Price has over 16 years of work experience in various roles within the pharmaceutical and healthcare industry. Kelly is currently serving as the US Head of Rare Disease at HRA Pharma. Prior to this, they worked as the VP of Market Access at Mahana Therapeutics from 2021 to 2022. From 2018 to 2021, they held the position of Vice President, Patient and Market Access at Osmotica Pharmaceutical Corp. In 2015, they were the President of Direct Success, Inc. Before that, they served as the Director of Market Access and Pharmacy at Medimetriks Pharmaceuticals, Inc. from 2013 to 2015. Kelly also worked as the Chief Operating Officer at Advanced Script Specialty Pharmacy from 2010 to 2013 and as an Immunology Sales Specialist at UCB from 2006 to 2010.
Kelly Price attended Baylor University from 1996 to 1998, where they pursued a Bachelor of Science degree in Nursing. Kelly'sfield of study was focused on Registered Nursing/Registered Nurse.
This person is not in any teams
This person is not in any offices
HRA Pharma
HRA Pharma is a fast growing, innovative consumer healthcare company, empowering people throughout the world to improve their lives by developing accessible, value added, self-care solutions. Historically centered on women’s health, the company has become the European leader in emergency contraception and in compromised skin. With ambitious projects in the pipeline, including innovative Rx-to-OTC switches, HRA Pharma is committed to bringing a range of innovative products and services to market, particularly in areas of unmet customer needs. Headquartered in Châtillon (France) with direct operational presence in 11 European countries and partnerships that have extended its products’ availability to over 71 countries worldwide, the company has a proven structure, the skills and experience to capture new consumer healthcare businesses and deliver high quality brands on a global scale. Visit www.hra-pharma.com for more information. HRA Pharma 200 rue de Paris 92320 Châtillon FRANCE Tel: +33 (0)1 40 33 11 30 Fax: +33 (0)1 40 33 12 31 Mail: careers@hra-pharma.com Information published here is not intended to promote medicines.